Back to BANK OF AMERICA CORP /DE/ BANK OF AMERICA CORP /DE/

RARERARE
6 quarters

Position history for BANK OF AMERICA CORP /DE/BANK OF AMERICA CORP /DE/'s holdings in ULTRAGENYX PHARMACEUTICAL IN

BANK OF AMERICA CORP /DE/ holds 1M shares of RARE (ULTRAGENYX PHARMACEUTICAL IN), worth $21.9M as of 2026-Q1. The position was decreased (-13.8% shares). RARE represents 0.0% of BANK OF AMERICA CORP /DE/'s portfolio.

Current Value

$21.9M

Current Shares

1M

Total Value Change

+$5.6M

Total Shares Change

+658,044

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
1M
-13.8%
$21.9M0.0%$22.07
0
2025-Q4
Increased
1.2M
+85.3%
$27.9M0.0%$22.78
45
2025-Q3
Increased
655,021
+2.7%
$19.7M0.0%$30.36
29
2025-Q2
Increased
637,690
+20.8%
$23.2M0.0%$36.52
34
2025-Q1
Increased
527,980
+35.9%
$19.1M0.0%$37.82
37
2024-Q4
New
388,502
-
$16.3M0.0%$42.27
39

Other major holders of RARE: Capital Research Global Investors, Capital International Investors, FEDERATED HERMES, INC.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used